Tuberculosis
Pai, Madhukar, Behr, Marcel A., Dowdy, David, Dheda, Keertan, Divangahi, Maziar, Boehme, Catharina C., Ginsberg, Ann, Swaminathan, Soumya +4 more·2016·Nature Reviews Disease Primers
Cited by (1,000)
Items 201–300 of 1,000
- STAT1 and CXCL10 involve in M1 macrophage polarization that may affect osteolysis and bone remodeling in extrapulmonary tuberculosisTuo Liang, Jiarui Chen, Guoyong Xu, Zide Zhang, Jiang Xue, Haopeng Zeng, Jie Jiang, Tianyou Chen, Zhaojie Qin, Hao Li et al. · 2021 · Gene
- A structural overview of mycobacterial adhesins: Key biomarkers for diagnostics and therapeuticsFlavia Squeglia, Alessia Ruggiero, Alfonso De Simone, Rita Berisio · 2017 · Protein Science
- Tuberkulose im ErwachsenenalterTom Schaberg, Folke Brinkmann, Cornelia Feiterna‐Sperling, Hilte Friederike Geerdes-Fenge, Pia Hartmann, Brit Häcker, Barbara Hauer, Walter Haas, Jan Heyckendorf, Christoph G. Lange et al. · 2022 · Pneumologie
- BTS clinical statement for the diagnosis and management of ocular tuberculosisOnn Min Kon, Nicholas A. V. Beare, David W. Connell, Erika Marie Damato, Thomas Gorsuch, Guy Hagan, Felicity Perrin, Harry Petrushkin, Jessica Potter, Charanjit S. Sethi et al. · 2022 · BMJ Open Respiratory Research
- CD4 T cell dysfunction is associated with bacterial recrudescence during chronic tuberculosisEvelyn Chang, Kelly Cavallo, Samuel M. Behar · 2025 · Nature Communications
- Dynamical Organization of Compositionally Distinct Inner and Outer Membrane Lipids of MycobacteriaPranav Adhyapak, Aswin T. Srivatsav, Manjari Mishra, Abhishek Singh, Rishikesh Narayan, Shobhna Kapoor · 2020 · Biophysical Journal
- Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary TuberculosisNathella Pavan Kumar, Kadar Moideen, Arul Nancy, Vijay Viswanathan, Kannan Thiruvengadam, Dina Nair, Vaithilingam V. Banurekha, Shanmugam Sivakumar, Syed S Hissar, Hardy Kornfeld et al. · 2020 · Clinical Infectious Diseases
- Diagnosis of opportunistic infectionsLesley Erica Scott, Pedro F. Silva, Catharina C. Boehme, Wendy Susan Stevens, Christopher M. Gilpin · 2017 · Current Opinion in HIV and AIDS
- The quest for vaccine-induced immune correlates of protection against tuberculosisElisa Nemes, Andrew J. Fiore-Gartland, César Boggiano, Margherita Coccia, Patricia D’Souza, Peter B. Gilbert, Ann M. Ginsberg, Ollivier Hyrien, Dominick J. Laddy, Karen W. Makar et al. · 2022 · Vaccine Insights
- Target Identification in Anti-Tuberculosis Drug DiscoveryRita Capela, Rita Félix, Marta Clariano, Diogo Nunes, Maria de Jesus Perry, Francisca Lopes · 2023 · International Journal of Molecular Sciences
- PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infectionAnneliese S. Ashhurst, Thaigarajan Parumasivam, John Gar Yan Chan, Leon C. W. Lin, Manuela Flórido, Nicholas P. West, Hak‐Kim Chan, Warwick J. Britton · 2018 · PLoS ONE
- Beyond the approved: target sites and inhibitors of bacterial RNA polymerase from bacteria and fungiSusanne H. Kirsch, F. P. Jake Haeckl, Rolf Müller · 2022 · Natural Product Reports
- Human genetics of mycobacterial diseaseMonica Dallmann-Sauer, Wilian Correa-Macedo, Erwin Schurr · 2018 · Mammalian Genome
- Modulating Iron for Metabolic Support of TB Host DefenseJames Joseph Phelan, Sharee A. Basdeo, Simone C. Tazoll, Sadhbh McGivern, Judit Rial Saborido, Joseph Keane · 2018 · Frontiers in Immunology
- Host Immune-Metabolic Adaptations Upon Mycobacterial Infections and Associated Co-MorbiditiesAlba Llibre, Martin J Dedicoat, Julie G. Burel, Caroline Demangel, Matthew K. O’Shea, Claudio Mauro · 2021 · Frontiers in Immunology
- Development of Inhalable ATRA-Loaded PLGA Nanoparticles as Host-Directed Immunotherapy against TuberculosisAhmad Z. Bahlool, Sarinj Fattah, Andrew O’Sullivan, Brenton Cavanagh, Ronan J. MacLoughlin, Joseph Keane, Mary P. O’Sullivan, Sally‐Ann Cryan · 2022 · Pharmaceutics
- Recent Advances in Pharmaceutical Approaches of Antimicrobial Agents for Selective Delivery in Various Administration RoutesArdiyah Nurul Fitri Marzaman, Tri Puspita Roska, Sartini Sartini, Rifka Nurul Utami, Sulistiawati Sulistiawati, Cindy Kristina Enggi, Marianti A. Manggau, Latifah Rahman, Venkatram Prasad Shastri, Andi Dian Permana · 2023 · Antibiotics
- Role of B Cells in Mycobacterium Tuberculosis InfectionPaul Stewart, Shivani Patel, Andrew Comer, Shafi Muneer, Uzma Nawaz, Violet Quann, Mira Bansal, Vishwanath Venketaraman · 2023 · Vaccines
- NIR-II aggregation-induced emission nanoparticles camouflaged with preactivated macrophage membranes for phototheranostics of pulmonary tuberculosisDingyuan Yan, Xue Li, Huanhuan Wang, Bin Li, Wei Wang, Yuhui Liao, Ben Zhong Tang, Dong Wang · 2025 · Nature Protocols
- Nontuberculous Mycobacteria and Heterologous Immunity to TuberculosisJaveed Ali Shah, Cecilia S. Lindestam Arlehamn, David J. de L. Horne, Alessandro Sette, Thomas R. Hawn · 2019 · The Journal of Infectious Diseases
- Inhaled Antibiotics for Mycobacterial Lung DiseaseBrandon J. H. Banaschewski, Thomas Hofmann · 2019 · Pharmaceutics
- Metabolic activity of mature biofilms of Mycobacterium tuberculosis and other non-tuberculous mycobacteriaAnna Solokhina, David Brückner, Gernot Bonkat, Olivier Braissant · 2017 · Scientific Reports
- Photoclick Reaction Constructs Glutathione-Responsive Theranostic System for Anti-TuberculosisJudun Zheng, Xun Long, Hao Chen, Zhisheng Ji, Bowen Shu, Rui Yue, Yechun Liao, Shengchao Ma, Kun Qiao, Ying Liu et al. · 2022 · Frontiers in Molecular Biosciences
- Single-cell profiling reveals distinct subsets of CD14+ monocytes drive blood immune signatures of active tuberculosisHannah Hillman, Nabeela A. Khan, Akul Singhania, Paige Dubelko, Ferran Soldevila, Rashmi Tippalagama, Aruna Dharshan De Silva, Bandu Gunasena, Judy Perera, Thomas J. Scriba et al. · 2023 · Frontiers in Immunology
- Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagyYilin Liu, Jiajun Wang, Jiayi Yang, Jiaojiao Xia, Jiaqi Yu, Dongsheng Chen, Yuhe Huang, Fen Yang, Yongdui Ruan, Jun‐Fa Xu et al. · 2024 · Journal of Nanobiotechnology
- Early and opposing neutrophil and CD4 T cell responses shape pulmonary tuberculosis pathologyBenjamin Henry Gern, Josepha M. Klas, Kimberly A. Foster, Molly E. Kanagy, Sara B. Cohen, Courtney Ray Plumlee, Fergal J. Duffy, Maxwell Lewis Neal, Mehnaz Halima, Andrew T. Gustin et al. · 2025 · The Journal of Experimental Medicine
- Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosisPhuong Chi Nguyen, Vincent Delorme, Anaïs Bénarouche, Alexandre Guy, Valérie Landry, Stéphane Audebert, Matthieu Pophillat, Luc Camoin, Céline Crauste, Jean‐Marie Galano et al. · 2018 · Bioorganic Chemistry
- Mycobacterium tuberculosis Rv3463 induces mycobactericidal activity in macrophages by enhancing phagolysosomal fusion and exhibits therapeutic potentialHye‐Soo Park, Yong Woo Back, Ki‐Won Shin, Hyun Shik Bae, Kang-In Lee, Han‐Gyu Choi, Seunga Choi, Hwang-Ho Lee, Chul Hee Choi, Jeong‐Kyu Park et al. · 2019 · Scientific Reports
- First clinical evaluation of the QIAreach TM QuantiFERON-TB for tuberculosis infection and active pulmonary diseaseKiyoyasu Fukushima, Kazumasa Akagi, A. Kondo, T. Kubo, Noriho Sakamoto, Hiroshi Mukae · 2021 · Pulmonology
- Impact of diagnostic strategies for tuberculosis using lateral flow urine lipoarabinomannan assay in people living with HIVRuvandhi R. Nathavitharana, Philip A. Lederer, Marty Chaplin, Stephanie Bjerrum, Karen R Steingart, Maunank Shah · 2021 · Cochrane Database of Systematic Reviews
- The pathogenesis of post-primary tuberculosis. A game changer for vaccine developmentRobert Lee Hunter, Jeffrey K. Actor · 2019 · Tuberculosis
- Latent Tuberculosis and HIV InfectionSara Hurtado Bares, Susan Swindells · 2020 · Current Infectious Disease Reports
- Host-Pathogen Dialogues in Autophagy, Apoptosis, and Necrosis during Mycobacterial InfectionJin Kyung Kim, Prashanta Silwal, Eun‐Kyeong Jo · 2020 · Immune Network
- Nuclease activity: an exploitable biomarker in bacterial infectionsJavier García González, Frank J. Hernández · 2022 · Expert Review of Molecular Diagnostics
- Antibiotic Resistance to Mycobacterium tuberculosis and Potential Use of Natural and Biological Products as Alternative Anti-Mycobacterial AgentsRoberto Arrigoni, Andrea Ballini, Skënder Topi, Lucrezia Bottalico, Emilio Jirillo, Luigì Santacroce · 2022 · Antibiotics
- Treatment of Latent Tuberculosis InfectionConnie A. Haley · 2017 · Microbiology Spectrum
- Influence of epidemiology, immunosuppressive regimens, clinical presentation, and treatment on kidney transplant outcomes of patients diagnosed with tuberculosis: A retrospective cohort analysisLaila Almeida Viana, Marina Pontello Cristelli, Daniel Wagner de Castro Lima Santos, Melissa G. Tavares, Marcus Taver Costa Dantas, Cláudia Rosso Felipe, Helio Tedesco Silva Junior, Jose Osmar Medina-Pestana · 2018 · American Journal of Transplantation
- Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosisVadim Makarov, Elena G. Salina, Robert C. Reynolds, Phyo Phyo Kyaw Zin, Sean Ekins · 2020 · Journal of Medicinal Chemistry
- Tracking down the White Plague. Chapter two: The role of endocranial abnormal blood vessel impressions and periosteal appositions in the paleopathological diagnosis of tuberculous meningitisOlga Spekker, Michael Schultz, László Paja, Orsolya Anna Váradi, Erika Molnár, György Pálfi, David R. Hunt · 2020 · PLoS ONE
- Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in DiseaseLindsey E. Fox, Marissa C. Locke, Deborah J. Lenschow · 2020 · Frontiers in Immunology
- Benchmarking Machine Learning Models to Assist in the Prognosis of TuberculosisMaicon Herverton Lino Ferreira da Silva Barros, Geovanne Oliveira Alves, Lubnnia Morais Florêncio Souza, Élisson da Silva Rocha, João Fausto Lorenzato de Oliveira, Theo Lynn, Vanderson de Souza Sampaio, Patrícia Takako Endo · 2021 · Informatics
- Stabilization of Hypoxia-Inducible Factor Promotes Antimicrobial Activity of Human Macrophages Against Mycobacterium tuberculosisSebastian F. Zenk, Sebastian Hauck, Daniel Mayer, Mark Grieshober, Steffen Stenger · 2021 · Frontiers in Immunology
- Evolution of cytokine production capacity in ancient and modern European populationsJorge Domínguez‐Andrés, Yunus Kuijpers, Olivier B. Bakker, Martin Jaeger, Cheng‐Jian Xu, Jos W. M. van der Meer, Mattias Jakobsson, Jaume Bertranpetit, Leo A. B. Joosten, Yang Li et al. · 2021 · eLife
- Defining Discriminatory Antibody Fingerprints in Active and Latent TuberculosisNadège Nziza, Deniz Cizmeci, Leela R. L. Davies, Edward B. Irvine, Wonyeong Jung, Brooke A. Fenderson, Marwou de Kock, Willem Albert Hanekom, Kees L. M. C. Franken, Cheryl L. Day et al. · 2022 · Frontiers in Immunology
- Beyond latent and active tuberculosis: a scoping review of conceptual frameworksS. M. Zaidi, A. Coussens, J. Seddon, T. Kredo, D. Warner, R. Houben, H. Esmail · 2023 · EClinicalMedicine
- Structure of mycobacterial respiratory complex ILiang, Yingke, Plourde, Alicia, Bueler, Stephanie A., Liu, Jun, Brzezinski, Peter, Vahidi, Siavash, Rubinstein, John L. · 2023 · Proceedings of the National Academy of Sciences
- Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based TherapyHsing-Wu Chen, Yao-Wen Kuo, Chung‐Yu Chen, Chin-Hao Chang, Su-Mei Wang, Ying‐Chun Chien, Jo‐Pai Chen, Jo-Pai Chen, Cheng‐Yu Chang, Yu‐Feng Wei et al. · 2024 · The Oncologist
- Anti-mycobacterial, -oxidative, -proliferative and -inflammatory activities of dichloromethane leaf extracts of Gymnosporia senegalensis (Lam.) LoesMarema Ephraim Makgatho, Winston Nxumalo, Lerato A. Raphoko · 2017 · South African Journal of Botany
- Creating demand for long-acting formulations for the treatment and prevention of HIV, tuberculosis, and viral hepatitisCharles W. Flexner, David L. Thomas, Susan Swindells · 2018 · Current Opinion in HIV and AIDS
- Galleria mellonella: An Infection Model for Screening Compounds Against the Mycobacterium tuberculosis ComplexMasanori Asai, Yan-Wen Li, Jasmeet Singh Khara, Brian D. Robertson, Paul Richard Langford, Sandra M. Newton · 2019 · Frontiers in Microbiology
- An Opportunity to END TB: Using the Sustainable Development Goals for Action on Socio-Economic Determinants of TB in High Burden Countries in WHO South-East Asia and the Western Pacific RegionsSrinath Satyanarayana, Pruthu Thekkur, Ajay M. V. Kumar, Yan Lin, Riitta A. Dlodlo, Mohammed Ahmed Khogali, Rony Zachariah, Anthony David Harries · 2020 · Tropical Medicine and Infectious Disease
- Experimental Pulmonary Tuberculosis in the Absence of Detectable Brain Infection Induces Neuroinflammation and Behavioural Abnormalities in Male BALB/c MiceJacqueline V. Lara-Espinosa, Ricardo A. Santana-Martínez, Perla D. Maldonado, Mario A. Zetter, Enrique Becerril‐Villanueva, Gilberto Pérez‐Sánchez, Lenin Pavón, Dulce Mata‐Espinosa, Jorge Barrios‐Payán, Manuel Othoniel López-Torres et al. · 2020 · International Journal of Molecular Sciences
- Global Control of Tuberculosis: Current Status and Future ProspectsFei Huang, Yanlin Zhao · 2022 · Zoonoses
- Glutathione Modulates Efficacious Changes in the Immune Response against TuberculosisArbi Abnousian, Joshua Vasquez, Kayvan Sasaninia, Melissa Kelley, Vishwanath Venketaraman · 2023 · Biomedicines
- Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting MacrophagesAnirudh Gairola, Aaron B. Benjamin, Joshua D. Weatherston, Jeffrey D. Cirillo, Hung‐Jen Wu · 2022 · Advanced Therapeutics
- Mycobacterium Tuberculosis Infection after Kidney Transplantation: A Comprehensive ReviewBogdan Marian Sorohan, Gener Ismail, Dorina Tacu, Bogdan Obrișcă, Gina Ciolan, Costin Gîngu, Ioanel C. Sinescu, Catalin Baston · 2022 · Pathogens
- Molecular degree of perturbation of plasma inflammatory markers associated with tuberculosis reveals distinct disease profiles between Indian and Chinese populationsDeivide Oliveira-de-Souza, Caian L. Vinhaes, María B. Arriaga, Nathella Pavan Kumar, Juan Manuel Cubillos-Angulo, Ruiru Shi, Wang Wei, Xing Yuan, Guolong Zhang, Ying Cai et al. · 2019 · Scientific Reports
- POTENTIALITIES OF IMMUNOLOGICAL TESTS IN THE DIAGNOSIS OF LATENT TUBERCULOSIS INFECTION AND TUBERCULOSISL. V. Slogotskaya, Mikhail Valerevich Sinitsyn, Dmitry Anatolievich Kudlay · 2019 · Tuberculosis and lung diseases
- Whole blood mRNA expression-based targets to discriminate active tuberculosis from latent infection and other pulmonary diseasesJéssica Dias Petrilli, Luana E. Araújo, Luciane Sussuchi da Silva, Ana Carolina Laus, Igor Müller, Rui Manuel Reis, Eduardo Martins Netto, Lee W. Riley, Sérgio Marcos Arruda, Adriano Queiroz · 2020 · Scientific Reports
- RNA-Seq Transcriptome Analysis of Peripheral Blood From Cattle Infected With Mycobacterium bovis Across an Experimental Time CourseKirsten E. McLoughlin, Carolina N. Correia, John Arthur Browne, David A. Magee, Nicolas Nalpas, Kévin Rue-Albrecht, Adam O. Whelan, Bernardo Villarreal‐Ramos, Hans Martin Vordermeier, Eamonn P. Gormley et al. · 2021 · Frontiers in Veterinary Science
- Fluorogenic RNA aptamer output sensors via transcription activated by recombinase polymerase amplification for nucleic acid testingJiajie Liang, Xin Liu, Wei Xiao, Peijun Teng, Ping Guan, Wanli Liang, Liangshan Hu, Guanbo He, Haorong He, Gan Li et al. · 2024 · Chemical Engineering Journal
- Identification of new anti-mycobacterial agents based on quinoline-isatin hybrids targeting enoyl acyl carrier protein reductase (InhA)Eman F. Khaleel, Ahmed Sabt, Małgorzata Korycka‐Machała, Rehab Mustafa Badi, Ninh The Son, Nguyen Xuan Ha, Mohamed Farouk Hamissa, Ahmed E. Elsawi, Eslam B. Elkaeed, Bozena R. Dziadek et al. · 2024 · Bioorganic Chemistry
- Incomplete transcripts dominate the Mycobacterium tuberculosis transcriptomeXiangwu Ju, Shuqi Li, Ruby Froom, Ling Wang, Mirjana Lilić, Madeleine Delbeau, Elizabeth A. Campbell, Jeremy M. Rock, Shixin Liu · 2024 · Nature
- Surgical treatment of spinal tuberculosis: an updated reviewJinjing Gan, Chuanzhi Zhang, Dagang Tang, Xing Du · 2024 · European journal of medical research
- Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art ReviewViolet N Chihota, Makaita Gombe, Amita Gupta, Nicole Salazar‐Austin, Theresa S. Ryckman, Christopher J. Hoffmann, Sylvia M. LaCourse, Jyoti S. Mathad, Vidya Mave, Kelly E. Dooley et al. · 2024 · Drugs
- HIV and the tuberculosis “set point”: how HIV impairs alveolar macrophage responses to tuberculosis and sets the stage for progressive diseaseSara C. Auld, Bashar S. Staitieh · 2020 · Retrovirology
- Diagnostic accuracy of TB-LAMP assay in patients with pulmonary tuberculosis–a case-control study in northern IndiaR. Yadav, Priya Daroch, Parakriti Gupta, Priyanka Agarwal, A.N. Aggarwal, Sunil Kumar Sethi · 2020 · Pulmonology
- Visualizing the dynamics of tuberculosis pathology using molecular imagingAlvaro A. Ordoñez, Elizabeth W. Tucker, Carolyn J. Anderson, Claire L. Carter, Shashank Ganatra, Deepak Kaushal, Igor Kramnik, Philana Ling Lin, Cressida A. Madigan, Susana Mendez et al. · 2021 · Journal of Clinical Investigation
- Tuberculosis amidst COVID-19 pandemic in India: unspoken challenges and the way forwardMainak Bardhan, Mohammad Mehedi Hasan, Ishita Ray, Anusua Sarkar, Priyanka Chahal, Sudhan Rackimuthu, Mohammad Yasir Essar · 2021 · Tropical Medicine and Health
- Next-Generation Metagenome Sequencing Shows Superior Diagnostic Performance in Acid-Fast Staining Sputum Smear-Negative Pulmonary Tuberculosis and Non-tuberculous Mycobacterial Pulmonary DiseasePeng Xu, Ke Yang, Lei Yang, Zhongli Wang, Fang Jin, Yubao Wang, Jing Feng · 2022 · Frontiers in Microbiology
- A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosisManse Kim, Claire E. Johnson, Alan A. Schmalstig, Ayano Annis, Sarah E. Wessel, Brian Van Horn, Amanda P. Schauer, Agata A. Exner, Jason E. Stout, Richard Hafner et al. · 2022 · Nature Communications
- IFN-γ independent markers of Mycobacterium tuberculosis exposure among male South African gold minersLeela R. L. Davies, Malisa T. Smith, Deniz Cizmeci, Stephanie Fischinger, Jessica Shih-Lu Lee, Lenette L. Lu, Erik D. Layton, Alison D. Grant, Katherine Fielding, Catherine M. Stein et al. · 2023 · EBioMedicine
- Design, synthesis and computational studies of new azaheterocyclic coumarin derivatives as anti- Mycobacterium tuberculosis agents targeting enoyl acyl carrier protein reductase (InhA)Rasha Z. Batran, Ahmed Sabt, Jarosław Dziadek, Asmaa F. Kassem · 2024 · RSC Advances
- Mycolyltransferase from Mycobacterium tuberculosis in covalent complex with tetrahydrolipstatin provides insights into antigen 85 catalysisChristopher M. Goins, Steven Dajnowicz, Micholas Dean Smith, Jerry M. Parks, Donald R. Ronning · 2018 · Journal of Biological Chemistry
- 1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activityFernanda Souza Macchi, Kenia Pissinate, Anne Drumond Villela, Bruno Lopes Abbadi, Valnês S. Rodrigues-Junior, Débora Dreher Nabinger, Stefani Altenhofen, Nathalia Denise de Moura Sperotto, Adílio da Silva Dadda, Fernanda Teixeira Subtil et al. · 2018 · European Journal of Medicinal Chemistry
- Role of VapBC12 Toxin-Antitoxin Locus in Cholesterol-Induced Mycobacterial PersistenceSakshi Talwar, Manitosh Pandey, Chandresh Sharma, Rintu Kutum, Josephine Lum, Daniel Carbajo, Renu Goel, Michael Poidinger, Debasis Dash, Amit Singhal et al. · 2020 · mSystems
- Repositioning of Isatin hybrids as novel anti-tubercular agents overcoming pre-existing antibiotics resistanceRakesh Kumar, Priya Takkar · 2021 · Medicinal Chemistry Research
- Expansion of social protection is necessary towards zero catastrophic costs due to TB: The first national TB patient cost survey in the PhilippinesJhiedon L. Florentino, Rosa Mia L. Arao, Anna Marie Celina Garfin, Donna Mae G. Gaviola, Carlos R. Tan, Rajendra Prasad Hubraj Yadav, Tom Hiatt, Fukushi Morishita, Andrew M. Siroka, Takuya Yamanaka et al. · 2022 · PLoS ONE
- Defining the role of neutrophils in the lung during infection: Implications for tuberculosis diseaseE. F. Gaffney, Dearbhla M Murphy, A. Walsh, Sarah A. Connolly, Sharee A. Basdeo, Joseph Keane, James Joseph Phelan · 2022 · Frontiers in Immunology
- Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoliMonica Dallmann-Sauer, Vinicius M. Fava, Stephanus Theron Malherbe, Candice E. MacDonald, Marianna Orlova, Elouise E. Kroon, Aurélie Cobat, Stéphanie Boisson‐Dupuis, Eileen Garner Hoal, Laurent Abel et al. · 2025 · Journal of Clinical Investigation
- Screening and identification of plasma lncRNAs uc.48+ and NR_105053 as potential novel biomarkers for cured pulmonary tuberculosisZhibin Li, Yu‐Shuai Han, Liliang Wei, Liying Shi, Wen‐Jing Yi, Jing Chen, Huai Huang, Tingting Jiang, Ji‐Cheng Li · 2020 · International Journal of Infectious Diseases
- CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV boxJoel Henrique Ellwanger, Valéria de Lima Kaminski, Andressa Gonçalves Rodrigues, Bruna Kulmann‐Leal, José Artur Bogo Chies · 2020 · International Journal of Immunogenetics
- Colorimetric Detection of Mycobacterium tuberculosis ESX-1 Substrate Protein in Clinical Samples Using Au@Pd Nanoparticle-Based Magnetic Enzyme-Linked Immunosorbent AssaySintayehu Kebede Gurmessa, Lemma Teshome Tufa, Jeonghyo Kim, Kang-In Lee, Young-Mi Kim, Van Tan Tran, Huu‐Quang Nguyen, Tae Sun Shim, Jeongkwon Kim, Tae Jung Park et al. · 2020 · ACS Applied Nano Materials
- Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosisWagdy Mohamed Eldehna, Mahmoud A. El Hassab, Nahla A. Abdelshafi, Fatma Al-Zahraa Sayed, Mohamed Farès, Sara T. Al‐Rashood, Zainab M. Elsayed, Marwa M. Abdel‐Aziz, Eslam B. Elkaeed, Mahmoud Elsabahy et al. · 2021 · International Journal of Pharmaceutics
- Prevalence of Diabetes Mellitus in Patients with Tuberculosis: A Prospective Cohort StudyPanyachot Buasroung, Tananchai Petnak, Prapaipim Liwtanakitpipat, Sasisopin Kiertiburanakul · 2022 · International Journal of Infectious Diseases
- A Structural View at Vaccine Development against M. tuberculosisMaria Romanò, Flavia Squeglia, Eliza Kramarska, Giovanni Barra, Han‐Gyu Choi, Hwa‐Jung Kim, Alessia Ruggiero, Rita Berisio · 2023 · Cells
- Alginate Nanoparticles: A Potential Drug Carrier in Tuberculosis TreatmentRakesh P. Patel, Geeta K. Patel, Nikunjana A. Patel, Sudarshan Kumar Singh, Chuda Chittasupho · 2023 · Springer eBooks
- Current approaches toward identifying a correlate of immune protection from tuberculosisIman Satti, Helen McShane · 2018 · Expert Review of Vaccines
- A Phage Therapy Guide for Clinicians and Basic Scientists: Background and Highlighting Applications for Developing CountriesAli Khalid, Ruby C.Y. Lin, Jonathan R. Iredell · 2021 · Frontiers in Microbiology
- Rapamycin modulates pulmonary pathology in a murine model of Mycobacterium tuberculosis infectionKamlesh Bhatt, Madhuri Bhagavathula, Sheetal Verma, Graham S. Timmins, Vojo P. Deretic, Jerrold J. Ellner, Padmini Salgame · 2021 · Disease Models & Mechanisms
- Stringent Response in Mycobacteria: From Biology to Therapeutic PotentialKuldeepkumar Ramnaresh Gupta, Gunjan Arora, Abid R. Mattoo, Andaleeb Sajid · 2021 · Pathogens
- Single-cell profiling identifies ACE + granuloma macrophages as a nonpermissive niche for intracellular bacteria during persistent Salmonella infectionTrung H.M. Pham, Yuan Xue, Susan M. Brewer, Kenneth E. Bernstein, Stephen R. Quake, Denise M. Monack · 2023 · Science Advances
- Tobacco smoke exposure recruits inflammatory airspace monocytes that establish permissive lung niches for Mycobacterium tuberculosisBjörn Corleis, Constantine N. Tzouanas, Marc H. Wadsworth, Josalyn L. Cho, Alice H. Linder, Abigail E. Schiff, Björn Zessin, Fabian Stei, Anca Dorhoi, Amy K. Dickey et al. · 2023 · Science Translational Medicine
- PE_PGRS3 of Mycobacterium tuberculosis is specifically expressed at low phosphate concentration, and its arginine-rich C-terminal domain mediates adhesion and persistence in host tissues when expressed in Mycobacterium smegmatisFlavio De Maio, Basem Battah, Valentina Palmieri, Linda Petrone, Francesco Corrente, Alessandro Salustri, Ivana Palucci, Silvia Bellesi, Massimiliano Papi, Salvatore Rubino et al. · 2018 · Cellular Microbiology
- Amino acid based prodrugs of a fosmidomycin surrogate as antimalarial and antitubercular agentsCharlotte Courtens, Martijn Risseeuw, Guy Caljon, Louis J.R.M. Maes, Anandi Martin, Serge Van Calenbergh · 2019 · Bioorganic & Medicinal Chemistry
- All trans retinoic acid as a host-directed immunotherapy for tuberculosisAhmad Z. Bahlool, Conor Grant, Sally‐Ann Cryan, Joseph Keane, Mary P. O’Sullivan · 2022 · Current Research in Immunology
- Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profileLeila Y. Chihab, Rebecca Kuan, Elizabeth Jane Phillips, Simon Alexander Mallal, Virginie Rozot, Mark M. Davis, Thomas J. Scriba, Alessandro Sette, Bjoern Peters, Cecilia S. Lindestam Arlehamn et al. · 2022 · HLA
- Electrochemical Biosensors Based on Carbon Nanomaterials for Diagnosis of Human Respiratory DiseasesChunmei Li, Bo Che, Linhong Deng · 2022 · Biosensors
- Advances in TB testingJayson V. Pagaduan, Ghaith Altawallbeh · 2023 · Advances in clinical chemistry
- Revisiting the role of mesenchymal stem cells in tuberculosis and other infectious diseasesAnnu Devi, Isha Pahuja, Manisha Singh, Akanksha Verma, Debapriya Bhattacharya, Ashima Bhaskar, Ved Prakash Dwivedi, Gobardhan Das · 2023 · Cellular and Molecular Immunology